ANAVEX LIFE SCIENCES CORP. Effect of Exchange Rate on Cash
ANAVEX LIFE SCIENCES CORP. (AVXL) reported Effect of Exchange Rate on Cash of $216.00 thousand for the 12-month period ending 2021-09-30, per its 10-K filed 2021-11-24.
Discontinued › Cash Flow › Change in Cash
us-gaap:EffectOfExchangeRateOnCash · last filed 2021-11-24
- ANAVEX LIFE SCIENCES CORP. effect of exchange rate on cash for fiscal 2021 was $216.00K, a 500.00% increase from fiscal 2020.
- ANAVEX LIFE SCIENCES CORP. effect of exchange rate on cash for fiscal 2020 was $36.00K.
- ANAVEX LIFE SCIENCES CORP. effect of exchange rate on cash for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- ANAVEX LIFE SCIENCES CORP. effect of exchange rate on cash for fiscal 2018 was $6.83M.
| Period end | Effect of Exchange Rate on Cash 12 month | Effect of Exchange Rate on Cash 12 month as first filed |
|---|---|---|
| 2021-09-30 | $216.00K 10-K · filed 2021-11-24 | |
| 2020-09-30 | $36.00K 10-K · filed 2021-11-24 | |
| 2019-09-30 | $0.00 10-K · filed 2020-12-28 | |
| 2018-09-30 | $6.83M 10-K · filed 2019-12-16 | $7.17M 10-K · filed 2018-12-12 |
| 2016-09-30 | -$11.00K 10-K · filed 2019-01-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |